{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T11:31:18Z","timestamp":1777721478777,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>AGAP2 (<jats:underline>A<\/jats:underline>rf GAP with <jats:underline>G<\/jats:underline>TP-binding protein-like domain, <jats:underline>A<\/jats:underline>nkyrin repeat and <jats:underline>P<\/jats:underline>H domain 2) isoform 2 is considered a proto-oncogene, but not much is known about <jats:italic>AGAP2<\/jats:italic> gene expression regulation. To get some insight into this process, <jats:italic>AGAP2<\/jats:italic> proximal promoter was cloned and characterised using reporter assays. We have identified SP1 as a transcription factor bound to <jats:italic>AGAP2<\/jats:italic> promoter and required for <jats:italic>AGAP2<\/jats:italic> expression in two different types of cancer cells (KU812, a chronic myeloid leukaemia cell line; and DU145, a prostate cancer cell line): silencing SP1 decreased AGAP2 protein levels. We have also found that all-trans retinoic acid (ATRA) treatment increased AGAP2 protein levels in both cell lines whilst curcumin treatment reduced ATRA-mediated AGAP2 increase. Furthermore, chromatin immunoprecipitation studies revealed the presence of RAR\u03b1, RXR\u03b1 and the lysine acetyl transferase PCAF in <jats:italic>AGAP2<\/jats:italic> promoter. Our results provide a novel understanding of <jats:italic>AGAP2<\/jats:italic> expression regulation that could be beneficial to those patients with cancers where AGAP2 is overexpressed.<\/jats:p>","DOI":"10.1038\/s41598-018-36888-x","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T11:32:59Z","timestamp":1548243179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["SP1 and RAR\u03b1 regulate AGAP2 expression in cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Yegor","family":"Doush","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif A.","family":"Surani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Navarro-Corcuera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"McArdle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Ellen","family":"Billett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9144-8809","authenticated-orcid":false,"given":"Cristina","family":"Montiel-Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"36888_CR1","doi-asserted-by":"publisher","first-page":"16441","DOI":"10.1074\/jbc.M312175200","volume":"279","author":"JY Ahn","year":"2004","unstructured":"Ahn, J. Y. et al. PIKE (phosphatidylinositol 3-kinase enhancer)-A GTPase stimulates Akt activity and mediates cellular invasion. J. Biol. Chem. 279, 16441\u201316451 (2004).","journal-title":"J. Biol. Chem."},{"key":"36888_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1158\/0008-5472.CAN-08-2537","volume":"69","author":"Y Cai","year":"2009","unstructured":"Cai, Y. et al. GGAP2\/PIKE-a directly activates both the Akt and nuclear factor-kappaB pathways and promotes prostate cancer progression. Cancer Res. 69, 819\u2013827 (2009).","journal-title":"Cancer Res."},{"key":"36888_CR3","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1091\/mbc.e10-11-0923","volume":"22","author":"K He","year":"2011","unstructured":"He, K., Jang, S. W., Joshi, J., Yoo, M. H. & Ye, K. Akt-phosphorylated PIKE-A inhibits UNC5B-induced apoptosis in cancer cell lines in a p53-dependent manner. Mol. Biol. Cell 22, 1943\u20131954 (2011).","journal-title":"Mol. Biol. Cell"},{"key":"36888_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/cdd.2015.66","volume":"23","author":"S Zhang","year":"2016","unstructured":"Zhang, S. et al. Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity. Cell Death Differ. 23, 52\u201363 (2016).","journal-title":"Cell Death Differ."},{"key":"36888_CR5","doi-asserted-by":"publisher","first-page":"13489","DOI":"10.1074\/jbc.M900469200","volume":"284","author":"Y Zhu","year":"2009","unstructured":"Zhu, Y. et al. Arf GTPase-activating protein AGAP2 regulates focal adhesion kinase activity and focal adhesion remodeling. J. Biol. Chem. 284, 13489\u201313496 (2009).","journal-title":"J. Biol. Chem."},{"key":"36888_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cellsig.2013.08.036","volume":"26","author":"S Dwane","year":"2014","unstructured":"Dwane, S., Durack, E., O\u2019Connor, R. & Kiely, P. A. RACK1 promotes neurite outgrowth by scaffolding AGAP2 to FAK. Cell. Signal. 26, 9\u201318 (2014).","journal-title":"Cell. Signal."},{"key":"36888_CR7","doi-asserted-by":"publisher","first-page":"7570","DOI":"10.1073\/pnas.0712306105","volume":"105","author":"R Liu","year":"2008","unstructured":"Liu, R. et al. Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. Proc. Natl. Acad. Sci. USA 105, 7570\u20137575 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"36888_CR8","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/emboj.2009.406","volume":"29","author":"CB Chan","year":"2010","unstructured":"Chan, C. B. et al. PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. EMBO J. 29, 956\u2013968 (2010).","journal-title":"EMBO J."},{"key":"36888_CR9","doi-asserted-by":"publisher","first-page":"6993","DOI":"10.1073\/pnas.0400921101","volume":"101","author":"JY Ahn","year":"2004","unstructured":"Ahn, J. Y., Hu, Y., Kroll, T. G., Allard, P. & Ye, K. PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt. Proc. Natl. Acad. Sci. USA 101, 6993\u20136998 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"36888_CR10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/MCB.01410-12","volume":"33","author":"MC Tse","year":"2013","unstructured":"Tse, M. C., Liu, X., Yang, S., Ye, K. & Chan, C. B. Fyn regulates adipogenesis by promoting PIKE-A\/STAT5a interaction. Mol. Cell. Biol. 33, 1797\u20131808 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"36888_CR11","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1083\/jcb.200806041","volume":"182","author":"RA Kahn","year":"2008","unstructured":"Kahn, R. A. et al. Consensus nomenclature for the human ArfGAP domain-containing proteins. J. Cell Biol. 182, 1039\u20131044 (2008).","journal-title":"J. Cell Biol."},{"key":"36888_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1242\/jcs.00924","volume":"117","author":"K Ye","year":"2004","unstructured":"Ye, K. & Snyder, S. H. PIKE GTPase: a novel mediator of phosphoinositide signaling. J. Cell. Sci. 117, 155\u2013161 (2004).","journal-title":"J. Cell. Sci."},{"key":"36888_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/aps.2013.71","volume":"34","author":"Q Qi","year":"2013","unstructured":"Qi, Q. & Ye, K. The roles of PIKE in tumorigenesis. Acta Pharmacol. Sin. 34, 991\u2013997 (2013).","journal-title":"Acta Pharmacol. Sin."},{"key":"36888_CR14","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1038\/sj.onc.1210290","volume":"26","author":"X Liu","year":"2007","unstructured":"Liu, X., Hu, Y., Hao, C., Rempel, S. A. & Ye, K. PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion. Oncogene 26, 4918\u20134927 (2007).","journal-title":"Oncogene"},{"key":"36888_CR15","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1038\/onc.2017.67","volume":"36","author":"Q Qi","year":"2017","unstructured":"Qi, Q. et al. Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression. Oncogene 36, 4562\u20134572 (2017).","journal-title":"Oncogene"},{"key":"36888_CR16","doi-asserted-by":"publisher","first-page":"e32708","DOI":"10.1371\/journal.pone.0032708","volume":"7","author":"Y Cai","year":"2012","unstructured":"Cai, Y., Wang, J., Ren, C. & Ittmann, M. Frequent heterogeneous missense mutations of GGAP2 in prostate cancer: implications for tumor biology, clonality and mutation analysis. PLoS One 7, e32708 (2012).","journal-title":"PLoS One"},{"key":"36888_CR17","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1128\/MCB.23.7.2476-2488.2003","volume":"23","author":"C Xia","year":"2003","unstructured":"Xia, C. et al. GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. Mol. Cell. Biol. 23, 2476\u20132488 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"36888_CR18","doi-asserted-by":"publisher","first-page":"235170","DOI":"10.1155\/2015\/235170","volume":"2015","author":"J Gamara","year":"2015","unstructured":"Gamara, J., Chouinard, F., Davis, L., Aoudjit, F. & Bourgoin, S. G. Regulators and Effectors of Arf GTPases in Neutrophils. J. Immunol. Res. 2015, 235170 (2015).","journal-title":"J. Immunol. Res."},{"key":"36888_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"36888_CR20","doi-asserted-by":"publisher","first-page":"6563","DOI":"10.1158\/1078-0432.CCR-11-1244","volume":"17","author":"TL Lotan","year":"2011","unstructured":"Lotan, T. L. et al. PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients. Clin. Cancer Res. 17, 6563\u20136573 (2011).","journal-title":"Clin. Cancer Res."},{"key":"36888_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.leu.2403241","volume":"18","author":"LS Steelman","year":"2004","unstructured":"Steelman, L. S. et al. JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18, 189\u2013218 (2004).","journal-title":"Leukemia"},{"key":"36888_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1365-2990.2005.00660.x","volume":"31","author":"CB Knobbe","year":"2005","unstructured":"Knobbe, C. B., Trampe-Kieslich, A. & Reifenberger, G. Genetic alteration and expression of the phosphoinositol-3-kinase\/Akt pathway genes PIK3CA and PIKE in human glioblastomas. Neuropathol. Appl. Neurobiol. 31, 486\u2013490 (2005).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"36888_CR23","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1021\/bi00231a027","volume":"30","author":"RC Snyder","year":"1991","unstructured":"Snyder, R. C., Ray, R., Blume, S. & Miller, D. M. Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry 30, 4290\u20134297 (1991).","journal-title":"Biochemistry"},{"key":"36888_CR24","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1523\/JNEUROSCI.0710-11.2011","volume":"31","author":"SF Sleiman","year":"2011","unstructured":"Sleiman, S. F. et al. Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration. J. Neurosci. 31, 6858\u20136870 (2011).","journal-title":"J. Neurosci."},{"key":"36888_CR25","first-page":"36","volume":"26","author":"JW Yarbro","year":"1966","unstructured":"Yarbro, J. W., Kennedy, B. J. & Barnum, C. P. Mithramycin inhibition of ribonucleic acid synthesis. Cancer Res. 26, 36\u201339 (1966).","journal-title":"Cancer Res."},{"key":"36888_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pharmthera.2015.05.008","volume":"152","author":"C Vizcaino","year":"2015","unstructured":"Vizcaino, C., Mansilla, S. & Portugal, J. Sp1 transcription factor: A long-standing target in cancer chemotherapy. Pharmacol. Ther. 152, 111\u2013124 (2015).","journal-title":"Pharmacol. Ther."},{"key":"36888_CR27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/0092-8674(91)90020-Y","volume":"65","author":"K Umesono","year":"1991","unstructured":"Umesono, K., Murakami, K. K., Thompson, C. C. & Evans, R. M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65, 1255\u20131266 (1991).","journal-title":"Cell"},{"key":"36888_CR28","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1073\/pnas.90.9.4281","volume":"90","author":"DM Heery","year":"1993","unstructured":"Heery, D. M. et al. Efficient transactivation by retinoic acid receptors in yeast requires retinoid X receptors. Proc. Natl. Acad. Sci. USA 90, 4281\u20134285 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"36888_CR29","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1210\/me.2005-0125","volume":"19","author":"P Chambon","year":"2005","unstructured":"Chambon, P. The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol. Endocrinol. 19, 1418\u20131428 (2005).","journal-title":"Mol. Endocrinol."},{"key":"36888_CR30","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1046\/j.1365-2141.1999.01240.x","volume":"104","author":"A Parrado","year":"1999","unstructured":"Parrado, A. et al. Alterations of the retinoic acid receptor alpha (RAR alpha) gene in myeloid and lymphoid malignancies. Br. J. Haematol. 104, 738\u2013741 (1999).","journal-title":"Br. J. Haematol."},{"key":"36888_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1080\/10428190290026358","volume":"43","author":"H Bruchova","year":"2002","unstructured":"Bruchova, H., Borovanova, T., Klamova, H. & Brdicka, R. Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea. Leuk. Lymphoma 43, 1289\u20131295 (2002).","journal-title":"Leuk. Lymphoma"},{"key":"36888_CR32","doi-asserted-by":"publisher","first-page":"9663","DOI":"10.1093\/nar\/gkt761","volume":"41","author":"CM Chan","year":"2013","unstructured":"Chan, C. M. et al. A signature motif mediating selective interactions of BCL11A with the NR2E\/F subfamily of orphan nuclear receptors. Nucleic Acids Res. 41, 9663\u20139679 (2013).","journal-title":"Nucleic Acids Res."},{"key":"36888_CR33","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1159\/000358724","volume":"33","author":"E Lin","year":"2014","unstructured":"Lin, E. et al. All-trans retinoic acid induces DU145 cell cycle arrest through Cdk5 activation. Cell. Physiol. Biochem. 33, 1620\u20131630 (2014).","journal-title":"Cell. Physiol. Biochem."},{"key":"36888_CR34","first-page":"580736","volume":"2012","author":"MC Chen","year":"2012","unstructured":"Chen, M. C. et al. Retinoic Acid Induces Apoptosis of Prostate Cancer DU145 Cells through Cdk5 Overactivation. Evid Based. Complement. Alternat Med. 2012, 580736 (2012).","journal-title":"Evid Based. Complement. Alternat Med."},{"key":"36888_CR35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<272::AID-IJC17>3.0.CO;2-X","volume":"80","author":"XP Lu","year":"1999","unstructured":"Lu, X. P., Fanjul, A., Picard, N., Shroot, B. & Pfahl, M. A selective retinoid with high activity against an androgen-resistant prostate cancer cell type. Int. J. Cancer 80, 272\u2013278 (1999).","journal-title":"Int. J. Cancer"},{"key":"36888_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1054\/bjoc.2001.1939","volume":"85","author":"LA Hammond","year":"2001","unstructured":"Hammond, L. A. et al. Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells. Br. J. Cancer 85, 453\u2013462 (2001).","journal-title":"Br. J. Cancer"},{"key":"36888_CR37","doi-asserted-by":"crossref","unstructured":"Kucukzeybek, Y. et al. Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145. J. Exp. Clin. Cancer Res. 27, 37-9966-27-37 (2008).","DOI":"10.1186\/1756-9966-27-37"},{"key":"36888_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2007.10.039","volume":"131","author":"CD Allis","year":"2007","unstructured":"Allis, C. D. et al. New nomenclature for chromatin-modifying enzymes. Cell 131, 633\u2013636 (2007).","journal-title":"Cell"},{"key":"36888_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0092-8674(00)81118-6","volume":"85","author":"Y Kamei","year":"1996","unstructured":"Kamei, Y. et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403\u2013414 (1996).","journal-title":"Cell"},{"key":"36888_CR40","doi-asserted-by":"publisher","first-page":"39402","DOI":"10.1074\/jbc.M307832200","volume":"278","author":"K Brown","year":"2003","unstructured":"Brown, K., Chen, Y., Underhill, T. M., Mymryk, J. S. & Torchia, J. The coactivator p\/CIP\/SRC-3 facilitates retinoic acid receptor signaling via recruitment of GCN5. J. Biol. Chem. 278, 39402\u201339412 (2003).","journal-title":"J. Biol. Chem."},{"key":"36888_CR41","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1074\/jbc.M116.745398","volume":"292","author":"Y Sunami","year":"2017","unstructured":"Sunami, Y. et al. Histone Acetyltransferase p300\/CREB-binding Protein-associated Factor (PCAF) Is Required for All-trans-retinoic Acid-induced Granulocytic Differentiation in Leukemia Cells. J. Biol. Chem. 292, 2815\u20132829 (2017).","journal-title":"J. Biol. Chem."},{"key":"36888_CR42","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1042\/BST20160081","volume":"44","author":"JA Brown","year":"2016","unstructured":"Brown, J. A., Bourke, E., Eriksson, L. A. & Kerin, M. J. Targeting cancer using KAT inhibitors to mimic lethal knockouts. Biochem. Soc. Trans. 44, 979\u2013986 (2016).","journal-title":"Biochem. Soc. Trans."},{"key":"36888_CR43","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1158\/0008-5472.CAN-07-6805","volume":"68","author":"G Chadalapaka","year":"2008","unstructured":"Chadalapaka, G. et al. Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res. 68, 5345\u20135354 (2008).","journal-title":"Cancer Res."},{"key":"36888_CR44","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.bbrc.2006.10.159","volume":"351","author":"J Nomura","year":"2006","unstructured":"Nomura, J. et al. All-trans retinoic acid increases expression of aquaporin-5 and plasma membrane water permeability via transactivation of Sp1 in mouse lung epithelial cells. Biochem. Biophys. Res. Commun. 351, 1048\u20131053 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"36888_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12026-015-8658-9","volume":"62","author":"HG Xu","year":"2015","unstructured":"Xu, H. G. et al. All-trans retinoic acid up-regulates the human CD2AP gene expression through Sp1\/Sp3 binding sites. Immunol. Res. 62, 273\u2013279 (2015).","journal-title":"Immunol. Res."},{"key":"36888_CR46","doi-asserted-by":"publisher","first-page":"37521","DOI":"10.1074\/jbc.M110.132795","volume":"285","author":"P Kumar","year":"2010","unstructured":"Kumar, P., Garg, R., Bolden, G. & Pandey, K. N. Interactive roles of Ets-1, Sp1, and acetylated histones in the retinoic acid-dependent activation of guanylyl cyclase\/atrial natriuretic peptide receptor-A gene transcription. J. Biol. Chem. 285, 37521\u201337530 (2010).","journal-title":"J. Biol. Chem."},{"key":"36888_CR47","doi-asserted-by":"publisher","first-page":"10799","DOI":"10.1074\/jbc.M111.321836","volume":"287","author":"JH Shi","year":"2012","unstructured":"Shi, J. H., Zheng, B., Chen, S., Ma, G. Y. & Wen, J. K. Retinoic acid receptor alpha mediates all-trans-retinoic acid-induced Klf4 gene expression by regulating Klf4 promoter activity in vascular smooth muscle cells. J. Biol. Chem. 287, 10799\u201310811 (2012).","journal-title":"J. Biol. Chem."},{"key":"36888_CR48","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.1073\/pnas.95.23.13501","volume":"95","author":"A Krumm","year":"1998","unstructured":"Krumm, A. et al. Long-distance transcriptional enhancement by the histone acetyltransferase PCAF. Proc. Natl. Acad. Sci. USA 95, 13501\u201313506 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"36888_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1749-0774.2005.tb00054.x","volume":"18","author":"PN Van","year":"2005","unstructured":"Van, P. N., Xinh, P. T., Kano, Y., Tokunaga, K. & Sato, Y. Establishment and characterization of A novel Philadelphia-chromosome positive chronic myeloid leukemia cell line, TCC-S, expressing P210 and P190 BCR\/ABL transcripts but missing normal ABL gene. Hum. Cell 18, 25\u201333 (2005).","journal-title":"Hum. Cell"},{"key":"36888_CR50","doi-asserted-by":"crossref","unstructured":"Khan, A. et al. JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. (2017).","DOI":"10.1093\/nar\/gkx1126"},{"key":"36888_CR51","doi-asserted-by":"publisher","first-page":"10881","DOI":"10.1093\/nar\/16.22.10881","volume":"16","author":"F Corpet","year":"1988","unstructured":"Corpet, F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16, 10881\u201310890 (1988).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36888-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36888-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36888-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:59:47Z","timestamp":1671253187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36888-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["36888"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-36888-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"11 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"390"}}